Aller au contenu principal
Profil bibliographique

Sike He

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

44Publications signalées
198Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Renal cell carcinoma treatmentRenal and related cancersCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical Imaging

Les publications récentes

Accès ouvert 2026 article OpenAlex

Association of the triglyceride-glucose index with prostate cancer risk and prognosis: a systematic review and meta-analysis

Haobo Cao, Sike He, Bo Li, Ning Luo et autres

The triglyceride-glucose (TyG) index has emerged as a convenient and reliable surrogate marker for insulin resistance (IR) and has been linked to an increased risk of several malignancies. However, its association with prostate cancer (PCa) risk remains uncertain. We therefore conducted a …

cn, us (code pays fourni par la source)

0 citations World Journal of Surgical Oncology
Accès ouvert 2026 review OpenAlex

Application of flipped classroom in surgical education: a systematic review and meta-analysis

Rui Cheng, Sike He, Yuan Wang, Huan Ren et autres

Background: Surgical education is crucial to patient care as it trains surgeons and equips medical students with knowledge and skills. Flipped classroom (FC) is an active teaching approach that has shown potential in medical education, but its impact on surgical education remains …

cn (code pays fourni par la source)

0 citations Frontiers in Medicine
2026 conference-abstract OpenAlex

A prospective, multi-center, phase Ib/II trial of first-line cadonilimab plus axitinib in advanced non–clear cell renal cell carcinoma.

Xu Hu, Xu Shi, Sike He, Junru Chen et autres

4501 Background: Non-clear cell renal cell carcinoma (nccRCC) is a rare and heterogeneous disease with limited treatment evidence. Patients with nccRCC generally respond less favorably to systemic immunotherapy than those with clear cell RCC. However,current evidence for the treatment of nccRCC remains …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2026 article OpenAlex

Pretreatment intratumoral mature TLSs in non-clear cell renal cell carcinoma are associated with response to immunotherapy rechallenge

Y D Tang, Junru Chen, Jue Hu, Dingbang Liu et autres

BACKGROUND: While immune checkpoint inhibitor (ICI)-based therapy has shown promising efficacy in patients with metastatic non-clear cell renal cell carcinoma (nccRCC) in the first-line setting, the optimal treatment following disease progression remains undefined. We aimed to investigate the efficacy, safety, and predictive …

cn (code pays fourni par la source)

1 citation Journal for ImmunoTherapy of Cancer
2026 conference-abstract OpenAlex

A prospective, multi-center, phase Ib/II trial of first-line cadonilimab plus axitinib in advanced non-clear cell renal cell carcinoma.

Xu Hu, Xu Shi, Sike He, Junru Chen et autres

506 Background: Non-clear cell renal cell carcinoma (nccRCC) is a rare and heterogeneous disease with limited treatment evidence. Patients with nccRCC generally respond less favorably to systemic immunotherapy than those with clear cell RCC. However, current evidence for the treatment of nccRCC …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2026 review OpenAlex

Diagnostic performance of FEV 1 /FEV 6 in detecting airway obstruction and chronic obstructive pulmonary disease: A systematic review and meta-analysis

Dongru Du, Sike He, Jiangyue Qin, Hao Wang et autres

Background Although the postbronchodilator FEV 1 /FVC is the gold standard for diagnosing COPD, it is not easily obtainable due to various reasons. This study aims to investigate whether FEV 1 /FEV 6 may serve as an easily accessible surrogate for FEV …

cn (code pays fourni par la source)

0 citations Chronic Respiratory Disease

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.